论文部分内容阅读
目的:探讨戊酸雌二醇联合坤宁安丸对女性更年期综合征患者血清激素水平及免疫功能影响。方法:收集我院就诊或住院治疗的120例更年期综合征患者,随机分为实验组和对照组,每组60例。对照组患者给予戊酸雌二醇治疗,实验组患者在对照组基础上给予坤宁安丸治疗。分别于治疗前后对患者血清卵泡刺激素(FSH)、雌二醇(E2)、CD3~+、CD4~+、CD8~+水平及Kupperman评分、临床疗效进行检测并比较。结果:与治疗前相比,治疗后两组患者的FSH、CD8~+、KI评分水平均下降(P<0.05),E2、CD3~+CD4~+水平均升高(P<0.05);与对照组相比,实验组患者的FSH、CD8~+、KI评分水平较低(P<0.05),E2、CD3~+、CD4~+水平较高,临床治疗总有效率较高(P<0.05)。结论:戊酸雌二醇联合坤宁安丸能够升高更年期综合征患者血清E2水平,降低FSH水平,并提高患者的免疫功能,临床疗效较好。
Objective: To investigate the effects of estradiol valerate combined with kuningan pills on serum hormone levels and immune function in women with menopausal syndrome. Methods: A total of 120 cases of climacteric syndrome patients treated in our hospital or hospitalized were randomly divided into experimental group and control group, with 60 cases in each group. The patients in the control group were treated with estradiol valerate. The patients in the experimental group were given kuningan pills on the basis of the control group. The serum levels of FSH, E2, CD3 +, CD4 +, CD8 + and Kupperman scores were measured and compared before and after treatment. Results: The levels of FSH, CD8 + and KI in both groups decreased (P <0.05) and the levels of E2 and CD3 + + CD4 + increased compared with that before treatment (P <0.05) Compared with the control group, the scores of FSH, CD8 ~ + and KI in the experimental group were lower (P <0.05), and the levels of E2, CD3 + and CD4 + were higher, and the total effective rate of clinical treatment was higher (P <0.05 ). Conclusion: Estradiol valerate combined with Kunningan Pill can elevate the level of serum E2, reduce the level of FSH in patients with menopausal syndrome, and improve the immune function of patients with good clinical curative effect.